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Abstract
Background: Although intraductal papillary mucinous neoplasm (IPMN) of the pancreas is
acceptable as a distinct disease entity, the concept of mucin-secreting biliary tumors has not been
fully established.
Case presentation: We describe herein a case of mucin secreting biliary neoplasm. Imaging
revealed a cystic lesion 2 cm in diameter at the left lateral segment of the liver. Duodenal
endoscopy revealed mucin secretion through an enlarged papilla of Vater. On the cholangiogram,
the cystic lesion communicated with bile duct, and large filling defects caused by mucin were
observed in the dilated common bile duct. This lesion was diagnosed as a mucin-secreting bile duct
tumor. Left and caudate lobectomy of the liver with extrahepatic bile duct resection and
reconstruction was performed according to the possibility of the tumor's malignant behavior.
Histological examination of the specimen revealed biliary cystic wall was covered by micropapillary
neoplastic epithelium with mucin secretion lacking stromal invasion nor ovarian-like stroma. The
patient has remained well with no evidence of recurrence for 38 months since her operation.
Conclusion: It is only recently that the term "intraductal papillary mucinous neoplasm (IPMN),"
which is accepted as a distinct disease entity of the pancreas, has begun to be used for mucin-
secreting bile duct tumor. This case also seemed to be intraductal papillary neoplasm with
prominent cystic dilatation of the bile duct.
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Some cases of papillary adenocarcinoma, cystadenocarci-
noma, cystadenoma, or papillomatosis have been
described as mucin-secreting biliary tumors [1-3].
Although intraductal papillary mucinous neoplasm
(IPMN) of the pancreas is acceptable as a distinct disease
entity, [4-6] the concept of mucin-secreting biliary tumors
has not been established [7,8]. Kim et al., first used the
term "IPMN" for nine cases of mucin-hypersecreting bile
duct tumor in 2000 [9], and the condition has been
described with increasing frequency in recent years [7,10-
12]. We herein report a case of mucin-secreting biliary
neoplasm that is clinicopathologically similar to IPMN of
the pancreas.
Case presentation
A 71-year-old Japanese woman was referred to our hospi-
tal for evaluation of her elevation of serum gamma
glutamyl transferase levels to 135 IU/L (reference value
16–73 IU/L), which were incidentally found in a bio-
chemical test in medical health check. She had no symp-
toms of epigastralgia or jaundice. Her physical
examination and past medical history was unremarkable.
She did not smoke or drink. The remainder of her serum
chemistries, complete blood count, and coagulation pro-
file were all normal. Serum levels of tumor marker such as
carcinoembryonic antigen (CEA) and carbohydrate anti-
gen 19-9 (CA19-9) were within normal limits.
Abdominal ultrasonography (US) and computed tomog-
raphy (CT) demonstrated a cystic lesion measuring 2.0 cm
in maximal diameter at the left lateral segment of the liver
with peripheral left lateral anterior subsegmental bile duct
(B3) dilation (Figure 1A, and 1B). Magnetic resonance
(MR) imaging also confirmed a cystic lesion at the left lat-
eral segment of the liver, but the presence of a mural nod-
ule in the cystic lesion or mucin was not confirmed
(Figure 2A,2B). MR cholangiography showed a cystic
lesion at the left lobe of the liver, but a filling defect in the
bile duct and a communication between the cystic lesion
and bile duct could not be defined (Figure 2C). Duode-
noscopy showed a widely patent papillary orifice with
extruded mucoid material, and endoscopic ultrasonogra-
phy (EUS) could not detect a tumor component in the
bile duct or cystic lesion (Figure 3A,3B). Endoscopic retro-
grade cholangiogram (ERC) demonstrated amorphous
filling defects in the common bile duct corresponding to
mucin, and percutaneous transhepatic cholangiograms
(PTC) revealed communication between the hepatic cyst
and the major bile duct (Figure 4A,4B). The cytological
examinations through both ERC and PTC routes were
negative for malignancy.
Left and caudate lobectomy of the liver with extrahepatic
bile duct resection and reconstruction was performed
because the lesion seemed to be a potential malignancy.
Gross examination of the resected specimens revealed no
obvious mass protruding into the lumen, and only a
markedly dilated bile duct was observed at a glance (Fig-
ure 5A). Microscopically, the cystically dilated bile duct
was lined by tall columnar epithelium with micropapil-
lary features and mucin hypersecretion, but the tall papil-
lary growth with fibrovascular cores or villous structures
showing mass component was not present (Figure
5B,5C). These neoplastic cells with hyperchromatic nuclei
and loss of cell polarity, lacking stromal invasion was
observed (Figure 5D). Ovarian-like stroma typically seen
in hepatobiliary cystadenomas was not observed in the
wall. On immunohistochemistry using standard streptavi-
din-biotin-peroxidase method, meoplastic cells were pos-
itive for MUC2 and MUC5AC, but negative for MUC1,
CK20. The patient has been well without any evidence of
recurrence for 38 months since her operation.
Discussion
While the concept of mucin-producing pancreatic tumors
is well-recognized, the concept of a mucin-secreting bil-
iary tumor has not been well-established. Considering the
shared embryonic origin of the two duct system [13],
mucin-secreting bile duct tumor, like an IPMN of the pan-
creas, may theoretically also exist. Based on the imaging
for intraductal papillary tumors of the bile duct, mucin
component was detected as filling defect at cholangiogra-
phy and the papillary tumor was detected as polypoid
mass in the dilated biliary tree as well as IPMN of pancreas
[1,12]. Zen et al., summarized pathological similarities
and differences between IPN of bile duct and IPMN of
pancreas [8]. Similar findings were intraductal papillary
proliferation with fibrovascular core, occasional mucin
hypersecretion, most of mucin profiles, and patient out-
come, while dissimilar findings were pointed out to be the
incidence of immunohistochemical cytokeratin 20
expression, the percentage of gastric-type tumors, and the
frequency of mucin hypersecretion. IPMN of the pancreas
is a grossly visible, non-invasive, mucin-producing, pre-
dominantly papillary epithelial neoplasm with varying
degree of cellular atypia, arising from pancreastic ducts
with duct dilatation [6]. A mass component of papillary
proliferation commonly seen in IPMN of pancreas was
absent and micropapillary proliferation was predominant
in our case, but the histological features of cystic dilated
duct with mucin hypersecreation, and moderate cellular
atypia were resemble with that of IPMN of pancreas. On
the other hand, hepatobiliary cystadenoma/adenocarci-
noma in middle-aged women have been reported to have
ovarian-like stroma [14,15] and a large number of these
cases would enter the disease entity of a mucinous cystic
neoplasm (MCN) of the pancreas [16]. Our case did not
have ovarian-like stroma in the cystic wall. These findings
and mucin profiles suggest that our biliary lesion resem-Page 2 of 7
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Abdominal ultrasonography (A) and computed tomography (B) show a cystic lesion measuring 2.0 cm in maximal diameter at the left lateral segment of the liver with peripheral left lateral anterior subsegmental bile duct (B3) dilatationFigure 1
Abdominal ultrasonography (A) and computed tomography (B) show a cystic lesion measuring 2.0 cm in maximal diameter at 
the left lateral segment of the liver with peripheral left lateral anterior subsegmental bile duct (B3) dilatation. Arrows head indi-
cate the cystic lesion.
World Journal of Surgical Oncology 2007, 5:98 http://www.wjso.com/content/5/1/98ble with cystic variant of intraductal papillary neoplasm of
the bile duct, proposed by Zen et al., [17]. Lim JH., [12]
have summarized the characteristics observed in the imag-
ing of IPMN of the bile duct from 15 cases, and our case is
compatible with these descriptions at an aneurysmal type.
Also in our case, ERC or PTC instead of US, CT, or MRI
made it possible to detect mucin. We therefore consider
that ERC or PTC is necessary to diagnose IPMN of the bile
duct.
According to the adenoma-carcinoma sequences in the
IPMN of the pancreas [18] we treated our case according
to the malignant behavior. Percutaneous transhepatic
cholangioscopy (PTCS) was recommended for the accu-
rate diagnosis of IPMN of the bile duct, [1,9,11] but we
did not perform PTCS because of its invasiveness, the time
required to complete the procedure, and the risk of malig-
nant seeding of the tract [1]. Lim JH et al., [12] have also
reported that 7 of 15 (47.3%) patients with IPMN of the
bile duct had multiple IPMN in their resected specimens.
Therefore, intraoperative cholangioscopy and frozen his-
tology should have been performed in our case. If frozen
histology had revealed no malignancy in this case, more
limited resection such as left lobectomy of the liver with-
out caudate lobectomy of the liver and extrahepatic bile
duct resection could have been performed.
If more cases of IPN of the bile duct are reported, consen-
sus could be achieved regarding the optimal and least
invasive preoperative evaluation and treatment plans such
as indications for surgery and the extent of resection.
Conclusion
It is only recently that the term "intraductal papillary
mucinous neoplasm (IPMN)," which is accepted as a dis-
tinct disease entity of the pancreas, has begun to be used
as "intraductal papillary neoplasm of the bile duct (IPN-
B)" for mucin-secreting bile duct tumor. If more cases of
Magnetic resonance imaging (MRI) reveals the cystic lesion as low in the T1-weighted image (A) and as high in the T2-weighted image (B)Figure 2
Magnetic resonance imaging (MRI) reveals the cystic lesion as low in the T1-weighted image (A) and as high in the T2-weighted 
image (B). MR cholangiography shows a cystic lesion at the left lobe of the liver, but a filling defect in the bile duct and a com-
munication between the cystic lesion and bile duct could not be defined (C). Arrows head indicate the cystic lesion.Page 4 of 7
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Endoscopic image of the duodenum shows mucin draining from a patulous papillary orifice (A)Figure 3
Endoscopic image of the duodenum shows mucin draining from a patulous papillary orifice (A). Endoscopic ultrasonography 
showed no mass protruding into the lumen in the bile duct and the cystic lesion at the left lateral segment of the liver (B).
Endoscopic retrograde cholangiography (A) shows a dilated common bile duct with defined filling defects corresponding to mucinFigure 4
Endoscopic retrograde cholangiography (A) shows a dilated common bile duct with defined filling defects corresponding to 
mucin. Percutaneous transhepatic cholangiography (B) also shows mucin in the common bile duct and a communication 
between the cystic lesion and bile duct. However, the filling defect corresponding to the tumor component in the cystic lesion 
could not be defined. Arrows head indicate mucin in the common bile duct.
World Journal of Surgical Oncology 2007, 5:98 http://www.wjso.com/content/5/1/98IPN of the bile duct are reported, consensus could be
achieved regarding the optimal and least invasive preop-
erative evaluation and treatment plans.
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